Morgan Stanley’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.6M Buy
2,854,205
+175,060
+7% +$1.39M ﹤0.01% 2715
2025
Q4
$16.2M Sell
2,679,145
-9,973
-0.4% -$59.4K ﹤0.01% 3132
2025
Q3
$15.4M Buy
2,689,118
+1,055,428
+65% +$5.4M ﹤0.01% 3140
2025
Q2
$8.23M Buy
1,633,690
+209,345
+15% +$1.12M ﹤0.01% 3616
2025
Q1
$9.23M Buy
1,424,345
+300,539
+27% +$2.67M ﹤0.01% 3408
2024
Q4
$8.25M Sell
1,123,806
-113,113
-9% -$892K ﹤0.01% 3562
2024
Q3
$9.26M Sell
1,236,919
-886,293
-42% -$7.7M ﹤0.01% 3484
2024
Q2
$18.9M Sell
2,123,212
-216,048
-9% -$2.07M ﹤0.01% 2725
2024
Q1
$23.7M Sell
2,339,260
-1,913,298
-45% -$19.5M ﹤0.01% 2514
2023
Q4
$42.8M Buy
4,252,558
+2,865,142
+207% +$26.2M ﹤0.01% 2616
2023
Q3
$13M Buy
1,387,416
+697,690
+101% +$9.95M ﹤0.01% 2874
2023
Q2
$16.9M Buy
689,726
+90,868
+15% +$2.28M ﹤0.01% 2640
2023
Q1
$13.9M Sell
598,858
-578,970
-49% -$14.8M ﹤0.01% 2828
2022
Q4
$29.8M Buy
1,177,828
+32,170
+3% +$789K ﹤0.01% 1957
2022
Q3
$22.1M Buy
1,145,658
+64,284
+6% +$1.63M ﹤0.01% 2077
2022
Q2
$27.5M Buy
1,081,374
+489,696
+83% +$11.4M ﹤0.01% 1934
2022
Q1
$15.2M Sell
591,678
-639,416
-52% -$19M ﹤0.01% 2427
2021
Q4
$51.5M Buy
1,231,094
+1,086,524
+752% +$42.6M 0.01% 1311
2021
Q3
$6.29M Sell
144,570
-194,647
-57% -$8.43M ﹤0.01% 3435
2021
Q2
$16M Sell
339,217
-63,424
-16% -$2.88M ﹤0.01% 2406
2021
Q1
$20.6M Buy
402,641
+308,307
+327% +$16.6M ﹤0.01% 1874
2020
Q4
$2.53M Buy
94,334
+53,525
+131% +$1.74M ﹤0.01% 3951
2020
Q3
$1.4M Buy
40,809
+12,350
+43% +$532K ﹤0.01% 3963
2020
Q2
$1.17M Buy
28,459
+10,073
+55% +$338K ﹤0.01% 4052
2020
Q1
$630K Buy
18,386
+2,934
+19% +$78.9K ﹤0.01% 4247
2019
Q4
$195K Buy
+15,452
New +$207K ﹤0.01% 5420

Other funds holding VIR